COMBINING LOOP WITH THIAZIDE DIURETICS FOR DECOMPENSATED HEART FAILURE: THE CLOROTIC TRIAL

Hospital d’Olot i comarcal de la Garrotxa, Universitat de Vic—Universitat Central de Catalunya, Hospital Universitari Arnau de Villanova, Hospital Universitario de Getafe, Complejo Hospitalario de Soria, Hospital Clínico Universitario ‘Lozano Blesa’,

The study evaluates the efficacy and safety of adding hydrochlorothiazide (HCTZ) to loop diuretics in managing patients with decompensated heart failure. It provides insights into diuretic response metrics, including changes in sodium and potassium levels, and assesses the impact on overall treatment outcomes. The trial's results contribute to understanding optimal diuretic strategies in heart failure management.